VIVA Physicians selects NAMSA to assess safety of paclitaxel drug-eluting technologies in PAD

Image: VIVA Physicians has selected NAMSA as statistical analytic group to assess safety of paclitaxel drug-eluting technologies in PAD. Photo: courtesy of Areeya / FreeDigitalPhotos.net.